Bolt Biotherapeutics
BOLT
BOLT
40 hedge funds and large institutions have $32.1M invested in Bolt Biotherapeutics in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less capital invested
Capital invested by funds: $32.4M → $32.1M (-$320K)
11% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 9
Holders
40
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$2.18M | |
| 2 | +$589K | |
| 3 | +$223K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$189K |
| 5 |
Squarepoint
New York
|
+$81.9K |
Top Sellers
| 1 | -$349K | |
| 2 | -$195K | |
| 3 | -$168K | |
| 4 |
NM
Newtyn Management
New York
|
-$147K |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$86.5K |